Bioventus Inc. 10-Q filing
Filed 2026-05-06 · Report date 2026-03-28 · 2026
Filing metadata
- Accession number
- 0001665988-26-000027
- Form type
- 10-Q
- CIK
- 0001665988
- Primary document
- https://www.sec.gov/Archives/edgar/data/1665988/000166598826000027/bvs-20260328.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bioventus Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $132.1M | - | - |
| Cost Of Revenue | $41.3M | - | - |
| Gross Profit | $90.8M | - | - |
| Operating Income | $8.4M | - | - |
| Net Income | $3.1M | - | - |
| Eps Basic | 0.05 | - | - |
| Eps Diluted | 0.04 | - | - |
| Cash And Equivalents | $35.8M | - | - |
| Total Assets | $650.5M | - | - |
| Total Liabilities | $416.3M | - | - |
| Shareholders Equity | $188.9M | - | - |
| Operating Cash Flow | $8.9M | - | - |
| Capital Expenditures | $574,000 | - | - |